- $104.83m
- $95.90m
- $37.92m
Annual income statement for BGM, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 57.1 | 64.9 | 46.5 | 25.1 | 37.9 |
| Cost of Revenue | |||||
| Gross Profit | 5.64 | 6.23 | 1.75 | 4.11 | 6.31 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 54.7 | 62.8 | 49.1 | 25.7 | 50.5 |
| Operating Profit | 2.39 | 2.1 | -2.61 | -0.564 | -12.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.36 | 1.56 | -7.9 | -2.14 | -19.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.11 | 1.37 | -8.12 | -1.52 | -20.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.15 | 1.08 | -7.78 | -1.44 | -19.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.15 | 1.08 | -7.78 | -1.44 | -19.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 13.9 | 4.52 | -32.6 | -5.72 | -5.28 |
| Special Dividends per Share |